PM

Peter Molloy

Firebrick Pharma Limited | Founder, Chief Executive Officer, Executive Chairman, Executive Director
Dr Molloy at Pharmacia was Managing Director of Australia/NZ operations and later Vice President for Strategic Marketing, responsible for the marketing of hundreds of pharmaceuticals across 22 countries. During his pharmaceutical career, he has directly launched 23 new pharmaceutical products and executed 40 international licensing or distribution deals. He was responsible for the creation and launch in Australia of Betadine Sore Throat Gargle, which subsequently became a leading OTC product in Australia and the inspiration for the development of Nasodine. He is a founder of Firebrick and co inventor on all the key Firebrick patents.

Company and Roles

Company
Title
Tenure
Since
FRE
FRE
Firebrick Pharma Limited
  • Founder
  • Chief Executive Officer
  • Executive Chairman
  • Executive Director
14yrs, 3mthApr 2012

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
FRE
FRE
Firebrick Pharma Limited
20/05/26032,056,017N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
FRE
FRE
Firebrick Pharma Limited
20/05/26
Buy
245,000$0.040$9,856On-market trade
FRE
FRE
Firebrick Pharma Limited
10/10/24
Buy
454,545$0.055$25,000Participation in share purchase plan
FRE
FRE
Firebrick Pharma Limited
27/06/24
Buy
500,000$0.057$28,437On-market trade
FRE
FRE
Firebrick Pharma Limited
20/06/23
Issued
530,000$0.150$79,500Placement
FRE
FRE
Firebrick Pharma Limited
20/06/23
Transfer
30,326,472$0.155$4,700,603Off-market transfer